Exclusive: Following Up Akebia, Johnson & Johnson's Research And License Agreement
February 17, 2017 at 10:21 AM EST
On Monday, Akebia Therapeutics Inc (NASDAQ: AKBA) signed a $1 million research and license agreement with Johnson & Johnson (NYSE: ...